252 related articles for article (PubMed ID: 7480706)
1. Brain lesions in patients with AIDS: H-1 MR spectroscopy.
Chang L; Miller BL; McBride D; Cornford M; Oropilla G; Buchthal S; Chiang F; Aronow H; Beck CK; Ernst T
Radiology; 1995 Nov; 197(2):525-31. PubMed ID: 7480706
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy.
Chinn RJ; Wilkinson ID; Hall-Craggs MA; Paley MN; Miller RF; Kendall BE; Newman SP; Harrison MJ
Radiology; 1995 Dec; 197(3):649-54. PubMed ID: 7480733
[TBL] [Abstract][Full Text] [Related]
3. MR spectroscopy and diffusion-weighted MR imaging in focal brain lesions in AIDS.
Chang L; Ernst T
Neuroimaging Clin N Am; 1997 Aug; 7(3):409-26. PubMed ID: 9376961
[TBL] [Abstract][Full Text] [Related]
4. [The role of brain magnetic resonance studies in the diagnostics of central nervous system lesions in HIV-1 positive patients].
Sokolska V; Knysz B; Czapiga E; Gasiorowski J; Sasiadek M; Gładysz A
Wiad Lek; 2006; 59(11-12):805-13. PubMed ID: 17427496
[TBL] [Abstract][Full Text] [Related]
5. [Clinical uses of proton magnetic resonance spectroscopy of the brain].
Laubenberger J; Bayer S; Thiel T; Hennig J; Langer M
Rofo; 1998 Jun; 168(6):539-49. PubMed ID: 9687944
[TBL] [Abstract][Full Text] [Related]
6. AIDS dementia complex: evaluation with proton MR spectroscopic imaging.
Barker PB; Lee RR; McArthur JC
Radiology; 1995 Apr; 195(1):58-64. PubMed ID: 7892496
[TBL] [Abstract][Full Text] [Related]
7. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.
Simone IL; Federico F; Tortorella C; Andreula CF; Zimatore GB; Giannini P; Angarano G; Lucivero V; Picciola P; Carrara D; Bellacosa A; Livrea P
J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):516-23. PubMed ID: 9576546
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
9. Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients.
Ernst TM; Chang L; Witt MD; Aronow HA; Cornford ME; Walot I; Goldberg MA
Radiology; 1998 Sep; 208(3):663-9. PubMed ID: 9722843
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance in AIDS-related encephalopathy].
Gualdi GF; Di Biasi C; D'Agostino A; Trasimeni G; Melone A
Clin Ter; 1995 Dec; 146(12):843-56. PubMed ID: 8681504
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging--autopsy correlations in AIDS.
Smirniotopoulos JG; Koeller KK; Nelson AM; Murphy FM
Neuroimaging Clin N Am; 1997 Aug; 7(3):615-37. PubMed ID: 9376971
[TBL] [Abstract][Full Text] [Related]
12. Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS.
Lu D; Pavlakis SG; Frank Y; Bakshi S; Pahwa S; Gould RJ; Sison C; Hsu C; Lesser M; Hoberman M; Barnett T; Hyman RA
Radiology; 1996 May; 199(2):423-8. PubMed ID: 8668788
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.
Bruhn H; Frahm J; Gyngell ML; Merboldt KD; Hänicke W; Sauter R; Hamburger C
Radiology; 1989 Aug; 172(2):541-8. PubMed ID: 2748837
[TBL] [Abstract][Full Text] [Related]
14. Acquired immunodeficiency syndrome: correlation of radiologic and pathologic findings in the brain.
Balakrishnan J; Becker PS; Kumar AJ; Zinreich SJ; McArthur JC; Bryan RN
Radiographics; 1990 Mar; 10(2):201-15. PubMed ID: 2326512
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases.
Chawla S; Zhang Y; Wang S; Chaudhary S; Chou C; O'Rourke DM; Vossough A; Melhem ER; Poptani H
J Comput Assist Tomogr; 2010; 34(6):836-41. PubMed ID: 21084897
[TBL] [Abstract][Full Text] [Related]
16. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
[TBL] [Abstract][Full Text] [Related]
17. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
[TBL] [Abstract][Full Text] [Related]
18. [Brain imaging in AIDS].
Bousson V; Brunereau L; Meyohas MC; Lévy C; Arrivé L; Berthet K; Marsot-Dupuch K; Tubiana JM
J Radiol; 1999 Feb; 80(2):99-107. PubMed ID: 10209706
[TBL] [Abstract][Full Text] [Related]
19. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.
Ernst T; Chang L; Melchor R; Mehringer CM
Radiology; 1997 Jun; 203(3):829-36. PubMed ID: 9169712
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy.
Van Den Heuvel AG; Van der Grond J; Van Rooij LG; Van Wassenaer-van Hall HN; Hoogenraad TU; Mali WP
Radiology; 1997 May; 203(2):539-43. PubMed ID: 9114118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
